$24.39
0.32 (+1.33%)
Par Pharmaceutical Companies, Inc. (PRX)
CAPS Rating:
The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

RSS Headlines
Fool UK